Geranylgeranyl transferase
From Proteopedia
(Difference between revisions)
Line 18: | Line 18: | ||
</StructureSection> | </StructureSection> | ||
- | ==3D structures of geranylgeranyl transferase== | ||
- | |||
- | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
- | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | |||
- | *Geranylgeranyl transferase type 1 | ||
- | |||
- | **[[1s64]] – rGGT1 α+β subunits + inhibitor - rat<br /> | ||
- | **[[1n4p]] – rGGT1 α+β subunits + GGPP<br /> | ||
- | **[[1n4s]], [[1n4r]] – rGGT1 α+β subunits + GGPP + peptide-GG containing CAAX <br /> | ||
- | **[[1tnb]], [[1tno]], [[1tnu]], [[1tny]], [[1tnz]], [[1n4q]] – rGGT1 α+β subunits + GGPP analog + peptide containing CAAX<br /> | ||
- | **[[3dra]] – GGT1 α+β subunits + GGPP – ''Candida albicans''<br /> | ||
- | |||
- | *Geranylgeranyl transferase type 2 | ||
- | |||
- | **[[1dce]] – rGGT2 α+β subunits – rat<br /> | ||
- | **[[3dss]] – rGGT2 α+β subunits <br /> | ||
- | |||
- | *Geranylgeranyl transferase type 2 complex | ||
- | |||
- | **[[6o60]] – GGT2 β subunit + FBXL2 + SKP1 - human <br /> | ||
- | **[[3c72]], [[3pz1]], [[3pz3]], [[4ehm]], [[4gts]], [[4gtt]], [[4gtv]] – rGGT2 α+β subunits + inhibitor<br /> | ||
- | **[[3hxb]], [[3hxc]], [[3hxd]], [[3hxe]], [[3hxf]] – rGGT2 α (mutant) +β subunits + inhibitor<br /> | ||
- | **[[1ltx]] – rGGT α+β subunits + tetra-alanine + Rab escort protein + farnesyl<br /> | ||
- | **[[3dst]] – rGGT2 α+β subunits + GGPP<br /> | ||
- | **[[3dsu]] – rGGT2 α+β subunits + farnesyl-PP<br /> | ||
- | **[[3dsv]], [[3dsw]], [[3dsx]] – rGGT2 α+β subunits + GG<br /> | ||
- | **[[3pz2]] – rGGT2 α+β subunits + GGPP + inhibitor<br /> | ||
- | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 09:58, 9 July 2019
|
References
- ↑ Lane KT, Beese LS. Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I. J Lipid Res. 2006 Apr;47(4):681-99. Epub 2006 Feb 13. PMID:16477080 doi:http://dx.doi.org/10.1194/jlr.R600002-JLR200
- ↑ Lawson MA, Coulton L, Ebetino FH, Vanderkerken K, Croucher PI. Geranylgeranyl transferase type II inhibition prevents myeloma bone disease. Biochem Biophys Res Commun. 2008 Dec 12;377(2):453-7. doi:, 10.1016/j.bbrc.2008.09.157. Epub 2008 Oct 16. PMID:18929536 doi:http://dx.doi.org/10.1016/j.bbrc.2008.09.157
- ↑ Guo Z, Wu YW, Das D, Delon C, Cramer J, Yu S, Thuns S, Lupilova N, Waldmann H, Brunsveld L, Goody RS, Alexandrov K, Blankenfeldt W. Structures of RabGGTase-substrate/product complexes provide insights into the evolution of protein prenylation. EMBO J. 2008 Sep 17;27(18):2444-56. Epub 2008 Aug 28. PMID:18756270 doi:10.1038/emboj.2008.164